Format

Send to

Choose Destination
See comment in PubMed Commons below
South Med J. 2007 Jul;100(7):701-8.

Treatment options for the management of perennial allergic rhinitis, with a focus on intranasal corticosteroids.

Author information

1
Cabarrus Family Medicine Residency Program, Charlotte, NC 28226, USA. OzDoc@aol.com

Abstract

Perennial allergic rhinitis (PAR) can have a significant impact on a patient's quality of life. While allergen avoidance is the first line of management for PAR, complete avoidance is difficult. Therapeutic options available for PAR include intranasal corticosteroids (INS), H1-antihistamines, decongestants and local chromones, as well as immunotherapy. For mild symptoms, INS and antihistamines are the standard of care, whereas for moderate-to-severe PAR, INS are the preferred therapy due to their proven efficacy. Patient quality of life and therapy preference play a role in maintaining adherence to treatment.

PMID:
17639750
DOI:
10.1097/SMJ.0b013e3180485560
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Southern Medical Association
    Loading ...
    Support Center